Hyagen News

Hyagen Media Kit Download | Regenerative Medicine Press Download Hyagen’s media kit for regenerative medicine coverage—expert bio, “As Seen On,” fast facts, story angles, logos, and booking info. Download the Hyagen Media Kit: Press Resources for Regenerative Medicine Journalists Regenerative medicine is one of the fastest-moving beats in modern healthcare—where innovation, regulation, patient safety, and marketing claims collide. If you’re a journalist, producer, editor, or

FDA regulatory frameworks have not changed. At the same time, peptide substances remain under active federal review, and visibility is increasing. FDA 503A Update: Peptides Remain Under Evaluation The FDA’s latest update to the 503A bulk drug substances list reinforces that many peptides are still within formal regulatory review processes, not approved for broad clinical use. Key highlights include: Updates across three categories: Category 1: Bulk drug substances under evalu

Hyagen Medical, a regulatory compliance and education company specializing in regenerative medicine, announced today the launch of a national initiative to equip healthcare providers with FDA-aligned training, biologics documentation tools, and patient education resources. The program aims to reduce regulatory risk and promote ethical, transparent practices as the regenerative medicine field faces increasing scrutiny from both regulators and the public.

Marketing regenerative medicine is high-risk if your claims outpace evidence or policy. Here’s how to stay educational, compliant, and discoverable. In this Grow Smarter podcast interview with Hyagen Medical Founder Chuck Meeker, host, Andrew Hong, Founder of Tobe Agency, dives deeper into Hyagen's practical, compliance-first training guide for regenerative medicine brands: including safer messaging, claim boundaries, Google policy realities, and PR strategies that build tru